Fresenius SE & Co KGaA
Fresenius SE & Co. KGaA is a major global healthcare company dedicated to providing high-quality products and specialized services for hospital operations, outpatient care, and complex medical procedures worldwide. The enterprise operates through two main business segments: Fresenius Kabi, which focuses on life-saving medicines, clinical nutrition solutions, infusion technologies, and intravenous devices, and Fresenius Helios, which manages a dominant network of private hospitals across Germany and Spain. Furthermore, the group retains a major equity stake in Fresenius Medical Care, a global leader in providing dialysis equipment, renal pharmaceuticals, and specialized care services for chronic kidney disease patients. The company's revenues are primarily derived from worldwide demand for essential pharmaceuticals, acute inpatient treatments, elective surgical care, and chronic medical management across expanding demographics. Operating on a massive global scale with hundreds of thousands of employees, the healthcare group manages dozens of production sites and acute facilities across multiple continents. Headquartered in Bad Homburg vor der Höhe, Germany, the company maintains its primary public equity listing on the Frankfurt Stock Exchange and is a core constituent of the DAX stock index.
75 of the funds FundTelligence covers report a position in Fresenius SE & Co KGaA.
- Legal name
- FRESENIUS SE & CO KGAA
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 75
- Exposure themes
- Ageing & Longevity, Age-Related Disease, Renal Care
Funds holding Fresenius SE & Co KGaA
- Fidelity Germany Fund — Fidelity · 5.1 % (largest positions only, October 2026)
- Sparinvest European Value — Sparinvest · 3.34 % (full portfolio disclosed, September 2026)
- DWS Invest German Equities — DWS · 1.98 % (full portfolio disclosed, June 2026)
- IKC Europa Flexibel — IKC Capital · 1.85 % (full portfolio disclosed, June 2026)
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 1.72 % (full portfolio disclosed, July 2026)
- Handelsbanken Europa — Handelsbanken · 1.5 % (full portfolio disclosed, October 2026)
- Nordea Global Stable Equity Fund - Unhedged — Nordea Funds · 1.37 % (full portfolio disclosed, July 2026)
- Sparinvest Ethical Global Value — Sparinvest · 1.37 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 75 funds holding it.